This 2254118-43-7, currently referred to as Mosunetuzumab, represents the important advance in the therapy field. It's an CD20 binding antibody-drug created for targeted introduction of radioactive substances directly https://allenpmvd146388.blogdigy.com/upifitamab-2254118-43-7-an-emerging-recent-antibody-drug-65159202